| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 87 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 87 |
| 2 | CYCLOPHOSPHAMIDE | 80 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 80 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 80 |
| 5 | FLUDARABINE PHOSPHATE | 71 |
| 6 | TACROLIMUS | 62 |
| 7 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 61 |
| 8 | TACROLIMUS OINTMENT 0.1% | 61 |
| 9 | CYCLOSPORINE | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 21 | 0.0076 |
| 1 | DEXMEDETOMIDINE HYDROCHLORIDE | 9 | 0.0030 |
| 2 | THIOTEPA | 29 | 0.0030 |
| 3 | BUSULFAN | 30 | 0.0019 |
| 4 | FLUDARABINE PHOSPHATE | 71 | 0.0018 |
| 5 | ALEMTUZUMAB | 29 | 0.0015 |
| 6 | FOSCARNET SODIUM | 6 | 0.0015 |
| 7 | MELPHALAN HYDROCHLORIDE | 37 | 0.0015 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 12 | 0.0014 |
| 9 | THIOGUANINE | 3 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 105 |
| 1 | Corticosteroid [EPC] | 90 |
| 2 | Mood Stabilizer [EPC] | 52 |
| 3 | Anti-epileptic Agent [EPC] | 46 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 42 |
| 5 | Kinase Inhibitor [EPC] | 32 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 31 |
| 7 | CD52-directed Cytolytic Antibody [EPC] | 29 |
| 8 | CD20-directed Cytolytic Antibody [EPC] | 24 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 29 | 0.0015 |
| 1 | Sigma-1 Agonist [EPC] | 10 | 0.0011 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 12 | 0.0009 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 5 | 0.0009 |
| 4 | Antimetabolite Immunosuppressant [EPC] | 15 | 0.0007 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 15 | 0.0007 |
| 6 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 7 | Alkylating Drug [EPC] | 105 | 0.0004 |
| 8 | CD19-directed Chimeric Antigen Receptor [EPC] | 4 | 0.0004 |
| 9 | Osmotic Diuretic [EPC] | 2 | 0.0004 |